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Abstract
Background
The inflammatory response has been implicated in the pathogenesis of left ventricular (LV)
remodeling after myocardial infarction (MI). An anthraquinone compound with anti-inflam-
matory properties, diacerein inhibits the synthesis and activity of pro-inflammatory cyto-
kines, such as tumor necrosis factor and interleukins 1 and 6. The purpose of this study was
to investigate the effects of diacerein on ventricular remodeling in vivo.
Methods and Results
Ligation of the left anterior descending artery was used to induce MI in an experimental rat
model. Rats were divided into two groups: a control group that received saline solution (n =
16) and a group that received diacerein (80 mg/kg) daily (n = 10). After 4 weeks, the LV vol-
ume, cellular signaling, caspase 3 activity, and nuclear factor kappa B (NF-κB) transcription
were compared between the two groups. After 4 weeks, end-diastolic and end-systolic LV
volumes were reduced in the treatment group compared to the control group (p< .01 and
p< .01, respectively). Compared to control rats, diacerein-treated rats exhibited less fibro-
sis in the LV (14.65%± 7.27% vs. 22.57%± 8.94%; p< .01), lower levels of caspase-3 activi-
ty, and lower levels of NF-κB p65 transcription.
Conclusions
Treatment with diacerein once a day for 4 weeks after MI improved ventricular remodeling by
promoting lower end-systolic and end-diastolic LV volumes. Diacerein also reduced fibrosis
in the LV. These effects might be associated with partial blockage of the NF-κB pathway.
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Introduction
Myocardial infarction (MI) is a devastating event, especially when reperfusion does not occur
[1, 2]. Left ventricular (LV) remodeling after MI involves enlargement of the LV and thinning
of the ventricular wall to maintain cardiac function[3]. The inflammatory response plays an
important role in LV remodeling [4]. For example, reperfusion injury can trigger a cascade of
signaling events that lead to inflammatory tissue damage. These signaling factors can include
pro-inflammatory cytokines, such as tumor-necrosis factor α (TNF-α), anti-inflammatory
molecules, adhesion molecules, and interleukins[5, 6].
TNF-α is a pro-inflammatory cytokine that participates in the innate immune system and is
expressed by cardiac tissues. At low levels, TNF-α exhibits a cardioprotective effect, whereas at
high levels, TNF-α has been shown to mediate detrimental effects [6, 7]. TNF-α has been impli-
cated in the pathogenesis of ventricular remodeling after MI [5, 8]. In clinical trials, blocking or
decreasing the bioavailability of TNF-α produced disappointing results in patients with conges-
tive heart failure [8, 9]. However, these patients had already undergone remodeling and dilation
of the LV, and the results may have been affected by the dichotomous effects of TNF-α.
To our knowledge, no clinical trial to date has evaluated the effects of anti-inflammatory in-
tervention on LV remodeling immediately after MI. However, there is some evidence that inhi-
bition of nuclear factor kappa B F-κB) improves LV remodeling and contributes to a decrease
in cardiac dysfunction after MI. Moreover, NF-κB is regulated, in part, by TNF-α [8, 10, 11].
Diacerein is an anthraquinone compound with anti-inflammatory properties that inhibit
the synthesis and activity of pro-inflammatory cytokines, such as TNF-α and interleukins 1
and 6 (IL-1 and IL-6, respectively)[12–14]. The active metabolite for diacereinis rhein
(1,8-dihydroxy-3-carboxyanthraquinone), which is found in plants of the genus Cassia and has
exhibited anti-inflammatory effects by inhibiting cytokine synthesis [14]. In the present study,
LV remodeling was evaluated in the presence ofdiacerein4 weeks after MI was induced in a
rat model.
Methods
Animals and Ethics Statement
Wistar rats had free access to water and a standard rat diet (State University of Campinas Cen-
tral Breeding Center, Campinas, Brazil), and were housed in a room maintained at 21°C with a
12-hour light/12-hourdark cycle. All experimental protocols were established in accordance
with the standards of the Brazilian Council in Animal Experimentation, and the “Guide for
Care and Use of Laboratory Animals” published by the US National Institutes of Health (NIH
Publication No. 85–23, revised 1996). The protocol was approved by the Institutional Commit-
tee on the Ethics of Animal Experiments of the State University of Campinas under the permit
number 2428–1.
Induction of MI and Study Protocol
Male Wistar rats (120–150g) were subjected to an MI event according to the method of Gao
et al.[15]. Briefly, rats were anesthetized with inhalation of 2% isoflurane with no endotracheal
tube placement. A thoracic incision was made over the left region of the chest, and a purse
string suture was made in the skin for incision closure at the end of the procedure. The thorax
was accessed through the fourth intercostal space, and the heart was gently popped out through
the incision.
MI was induced by performing a left coronary artery (LCA) ligation approximately 3 mm
from its origin using a 6–0 polypropylene suture. After ligation, the heart was immediately
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placed back into the chest, manual evacuation of air was performed, and the suture was closed
by snaring the previously placed purse string suture in the skin. If necessary, a needle was in-
serted into the eighth intercostal space to remove any residual pneumothorax. Rats were subse-
quently provided 40% oxygen and were monitored during recovery. All animals received
acetaminophen 200 mg.kg-1 per os for 3 days.
After induction of MI and total recovery from anesthesia, animals were treated daily for 4
weeks with either 80 mg/kg diacerein diluted with 2 ml of saline solution (Diacerein group;
n = 10) or a gavage of 2 ml of saline solution every day (Control group; n = 16). The diacerein
dose applied was selected based on previous studies [14, 16, 17]and unpublished data from our
laboratory. Two Sham groups were performed in the same way as described above with excep-
tion of no MI was induced by LCA ligation. One group was treated daily for 4 weeks with a ga-
vage of 2 ml of saline solution (Sham Group; n = 8) and the second group was treated daily for
4 weeks with 80mg/kg diacerein diluted with 2 ml of saline solution (Sham group with Diacer-
ein; n = 10). Body weights were recorded each week, and the diacerein dose administered was
corrected for changes in weight. After 4 weeks, animals were submitted to a hemodynamic
study and euthanasia for tissue harvesting. The euthanasia was induced with pentobarbital
100 mg.kg-1 and confirmed by the LV catheter inserted during the hemodynamic assessment.
Hemodynamic Assessment
Four weeks after the MI procedure, rats were anesthetized with xylazine (5 mg/kg) and keta-
mine (75 mg/kg) by intraperitoneal injection and were allowed to breathe spontaneously. A he-
modynamic invasive assay was performed by using apressure-volume catheter (SPR-838,
Millar Instruments, Houston, TX, USA) that was inserted into the LV cavity through the right
carotid artery. The pressure and volume of the LV were continuously monitored for correct po-
sitioning of the catheter. The catheter was coupled to a PowerLab 8/30 A/D converter (AD In-
struments; Mountain View, CA, USA) and a personal computer. Parallel conductance
correction volumes were determined after injection of 30% hypertonic saline solution (20 μL).
Upon completing the hemodynamic measurements, LV volume correction was determined by
using heparinized blood that was obtained from each animal. The blood was calibrated by cu-
vette, according to the method of Parcher and colleagues [18].
Histopathological Analysis
After the invasive hemodynamic assessment was completed, the rats were euthanized, and
their heart and lung tissues were harvested and weighed. The LV from each rat was dissected,
and a mid-ventricle slice (~ 3 mm) from each was preserved in 4% paraformaldehyde and em-
bedded in paraffin. Tissue sections (4μm) were stained with Masson’s trichrome and Picrosir-
ius Red to assess fibrosis and collagen deposition, respectively. Histological images were
acquired using an optical light microscope with a 2.5× lens (Imager A2 Axio Carl Zeiss, Ger-
many). On average, 12 images were needed to cover the entire LV slice. Images were recon-
structed to create a single panoramic slice using PTGui software (version 9.1.3, Rotterdam, The
Netherlands).
Fibrosis and collagen deposition were quantified using Image Pro Plus software (version
6.0,Warrendale, PA, USA). Data were expressed as a percentage of total tissue per LV pan-
oramic slice. Fibrosis and collagen deposition were also analyzed for the opposite LV wall
(remote area).
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Cross-sectional Area of Cardiomyocytes
To assess cardiac hypertrophy, the cross-sectional area (CSA) of the cardiomyocytes was calcu-
lated. Briefly, sections of the LV(4μm) were stained with hematoxylin and eosin (H&E) accord-
ing to Stefanon and collaborators [19]. Typically, 10 to 15 fields of the remote area were analyzed
using a40×objective lens and transmitted light. A total of 70 cells were measured for each animal
using Image Pro Plus software (version 6.0, Warrendale, PA, USA) for CSA assessment.
Protein Quantification by Western Blot
Samples of the LV tissue were snap-frozen in liquid nitrogen and stored at -80°C. Total protein
extraction was performed using RIPA buffer (1% (w/w) Nonidet P40, 1% (w/w) sodiumdeoxy-
cate, 0.1% (w/v) SDS, 150mmol/L NaCl, 50mmol/L HEPES pH 7.0, 2mmol/L EDTA pH 8.0,
100mmol/L NaF, 10% glycerol, 1.5mmol/L MgCl2, 100mmol/L PMSF in ETOH, 200mmol/L
sodium orthovanadate, 1 μg/ml aprotin), and samples were homogenized and centrifuged
prior to the determination of protein concentration in supernatants as previously described
[20]. Protein extracts (125 μg) were separated using 8% or 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes.
These membranes were incubated with primary antibodies for IkB-α, pIkB-α, TNFR1, TNFR2,
and Pro-COL 1A2 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Alkaline phospha-
tase-conjugated secondary antibodies were used (Thermo Scientific, West Palm Beach, FL,
USA).Bound antibodies were visualized using a biochemiluminescent detection system accord-
ing to the manufacturer’s instructions (Invitrogen Carlsbad, CA, USA). All immunoblotting
signals were normalized to densitometric data obtained for the corresponding membranes
stained with Ponceau, as previously described [21, 22]. Blots were imaged using a charge-cou-
pled device (CCD) camera (Gel Logic Imaging System, Rochester, NY, USA).
Transcription activity assay of NF-κB-Subunits p50 and p65
Activation of NF-κB p50 and p65 in nuclear extracts prepared from LV tissues was assayed
using a commercially available kit and a chemiluminescent detection method according to the
manufacturer’s instructions (Thermo Scientific).
Caspase 3/7 Activity
Caspase 3/7 activity was assayed for each LV protein extract (200 mg) according to the manu-
facturer’s instructions (Caspase/Glo 3/7, Promega, Fitchburg, WI, USA). Data were recorded
using a Glomax 20/20 luminometer (Promega).
Gene Expression
Infarct samples and remote tissues from the LV were subjected to RNA extraction using Trizol
reagent (Ambion, USA). RNA was quantified using 260/280 nm absorbance ratio data. Using a
High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Carlsbad, CA, USA),
total RNA (1 g) was used for reverse transcription reactions. To detect levels of gene expres-
sion, real-time PCR was performed using commercially available Taqman primers for IL-1,
IL-6, TNF, NF-κB p50, NF-κB p65, and actin (Applied Biosystems, Carlsbad, CA, USA). De-
tection of actin was used as an internal control.
Statistical Analysis
All data are reported as the mean ± standard deviation (SD).The Shapiro-Wilk test for normal-
ity was performed. Statistical significance was analyzed by using an unpaired t-test or Mann-
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Whitney test when appropriate. Statistical analyses were performed using GraphPad Prism
software (for Mac, version 6, San Diego, CA, USA).
Results
Animal Weight, LVWeight, LV/BodyWeight Index, and LV Fibrosis
Four weeks after MI, the mean body weight of the Control group was greater than that of the
Diacerein group, although both groups exhibited a similar mean weight at the beginning of the
study. The Sham group treated with diacerein also exhibited a lower mean body weight com-
pared with the Sham only group. The LV/body weight index values were also higher for the
Control and Diacerein groups compared with the Sham and Sham plus diacerein groups 4
weeks post-MI. Using Masson’s trichrome staining, less fibrosis was detected for the Diacerein
group compared to the Control group (Fig. 1A) and lower collagen content was observed with
Picrosirius Red staining (Table 1). Morphometric analysis further revealed that the Diacerein
group had a lower cardiomyocyte CSA compared to the Control group in the remote LV area
(Fig. 1B).
Fig 1. Cardiomyocyte CSA in the remotemyocardial region indicated less hypertrophy in the Diacerein group compared to the Control group (A).
Fibrosis of the LV was reduced for the Diacerein group (B). Differences between groups were tested by ANOVA test and multiple comparison between
groups were tested using Tukey’s test. All values represent the mean ± SE of twelve experiments.
doi:10.1371/journal.pone.0121842.g001
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Diacerein Promotes Better Hemodynamics 4Weeks after MI
When lower end-diastolic and end-systolic volumes were monitored, improved LV remodeling
was observed for the Diacerein group compared to the Control group. The ejection fraction
was also higher for the Diacerein group compared to the Control group. The Control group
showed higher dP/dt max and heart rate values compared to the Diacerein group. However,
when dP/dt max was normalized to the end-diastolic volume (EDV), the latter of which is a
more reliable contractility index [23, 24], higher contractility index values were observed com-
pared to the Control group. In contrast, the Sham group treated with diacerein exhibited lower
contractility index values compared with the Sham group, and higher values compared with
the Control group. These data are summarized in Table 2.
Table 1. Body weight, lung weight, LV weight, and fibrosis.
Parameter Sham Group (n = 8) Control group (n = 16) Sham Group with Diacerein (n = 10) Diacerein group (n = 10) P-value
Initial BW (±g) 132.23 ± 25.10 144.67 ± 30.10 130.83 ± 7.90 128.73 ± 23.89 .11
BW after 4 wk (±g) 340.30 ± 24.31 282.78 ± 24.48* 272.59 ± 15.25* 257.40 ± 18.38 *,# <.01
LV (±g) 0.60 ± 0.04 0.68 ± 0.10 0.59 ± 0.09 0.64 ± 0.05 .05
LV/BW × 1000 1.79 ± 0.14 2.38 ± 0.20 * 1.88 ± 0.15# 2.51 ± 0.24 *, $ <.01
LW/BW × 1000 3.93 ± 0.84 6.91 ± 2.28* 4.1 ± 0.33# 6.80 ± 1.93*, $ <.01
LV fibrosis, % 1.79 ± 0.36 22.57 ± 8.94 *, $ 1.10 ± 0.35# 14.65 ± 7.27 *,#, $ <.01
LV collagen, % 0.81 ± 0.32 12.35 ± 6.38* 0.87 ± 0.29# 9.08 ± 6.77*,$ <.01
Lateral wall fibrosis, % 0.68 ± 0.48 3.99 ± 2.88* 0.60 ± 0.46# 3.61 ± 2.48*,$ <.01
BW indicates body weight; LW, lung weight. Data are expressed as mean ± SD. Differences between groups were tested by ANOVA test.
* P <. 05 vs. Sham group.
# P <. 05 vs. Control group.
$ P <. 05 vs. Sham group with Diacerein using Tukey’s test for multiple comparisons.
doi:10.1371/journal.pone.0121842.t001
Table 2. Hemodynamic data.
Parameter Sham Group
(n = 8)
Control group
(n = 16)
Sham Group with Diacerein
(n = 10)
Diacerein group
(n = 10)
P-
value
TAU, ms 10.56 ± 1.73 16.60 ± 6.36* 11.36 ± 1.83# 17.43 ± 4.86* <.01
dP/dt max, mmHg/s 7835 ± 1172 6288 ± 1678 4408 ± 799*, # 4714 ± 2072*,# <.01
dP/dt min, mmHg/s -8360 ± 1606 -4550 ± 1288* -3450 ± 635* -3698 ± 1653* <.01
dP/dt max/EDV, mmHg/
sμL-1
170.20 ± 25.47 50.17 ± 13.39* 93.42 ± 16.93*, # 75.08 ± 33.00*. # <.01
HR, bpm 277 ± 53 311 ± 86 244 ± 37# 247 ± 20# .02
Stroke volume, μL 16.03 ± 4.28 41.51 ±26.61* 16.12 ± 4.02# 42.28 ± 21.22*, $ <.01
EDV, μL 46.02 ± 26.69 125.3 ± 69.83* 47.18 ± 25.82# 62.78 ± 52.64# <.01
ESV, μL 35.55 ± 26.66 110.6 ± 66.52* 40.22 ± 25.50# 46.83 ± 66.03# <.01
EF, % 51.07 ± 33.71 23.21 ± 17.93* 46.85 ± 28.69# 50.86 ± 20.39# .03
TAU indicates time constant of isovolumic relaxation; HR, heart rate; bpm, beats per minute; EDV: end-diastolic LV volume; ESV: end-systolic LV volume;
EF: ejection fraction of LV.Data are expressed as mean ± SD. Differences between groups were tested by ANOVA test.
* P <. 05 vs. Sham group.
# P <. 05 vs. Control group.
$ P <. 05 vs. Sham group with Diacerein using Tukey’s test for multiple comparisons.
doi:10.1371/journal.pone.0121842.t002
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Diacerein Inhibits IκBα and TNF Receptor 1, Modulates NF-κB p65
Transcription, and Promotes Lower Levels of Caspase 3/7Activity
Lower levels of TNF receptor 1 (TNFR1) expression (Fig. 2A) and IκBα activation (Fig. 2B)
were detected for the Diacerein group compared to the Control group 4 weeks after MI. The
latter result corresponded to lower levels of NF-κB p65 transcription for the Diacerein group
(Fig. 3B). The levels of caspase 3/7 activity (Fig. 2D) and procollagen 1 and 2 deposition
Fig 2. RepresentativeWestern blot results that show inhibition of TNFR1 (A) and IκBα (B), no effect on
TNFR2 (C), lower caspase 3/7 activity (D), and lower procollagen deposition (E) in the Diacerein
group. All values represent means ± SE of five independent experiments. A.U.: arbitrary units.
doi:10.1371/journal.pone.0121842.g002
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(Fig. 2E) were also lower for the Diacerein group compared to the Control group. In contrast,
expression levels of NF-κBp50 were similar between the two groups (Fig. 3A).
Diacerein Promotes Lower TNFGene Expression in Infarcted and
Remote Areas of the LV
After administration of diacerein for 4 weeks, levels of TNF gene expression were lower in both
remote and infarcted areas of the LV (Fig. 4A). In contrast, levels of IL-1 gene expression did
not significantly differ between the two groups, although lower levels of IL-1expression were
detected for the Diacerein group (Fig. 4B). In the remote ventricle regions, lower levels of NF-
κB p65 gene expression were detected in the Diacerein group compared to the Control group.
The NF-κB p50 and IL-6 gene expression were not significantly different in the Diacerein
group compared to the Control group (Fig. 4C).
Discussion
This study demonstrates the beneficial effects of an anti-inflammatory drug, diacerein, on LV
remodeling in a rat experimental model of MI. Lower end-systolic and end-diastolic LV vol-
umes, higher LV ejection fractions, less hypertrophy of cardiomyocytes in remote areas, and
lower heart rates were detected in rats 4 weeks after an MI event and treatment with diacerein.
Lower dP/dt max values were observed in the treatment group compared to the control and
sham groups, and these data suggest that diacerein mediates a detrimental effect on myocardial
contractility. However, there were no differences observed after the dP/dt max values were nor-
malized to the EDVs. Lower dP/dt max values were also observed following normalization to
EDV values for the Sham group treated with diacerein compared with the Sham group. The lat-
ter data may indicate that greater modulation of the parasympathetic system occurred [25].
However, further studies are needed to examine this possibility.
The linearity between dP/dtmax and EDV reported in the literature suggest this index
might be a more reliable to assess the contractility state in vivo [23, 26]. Of note, most of the
studies that have used dP/dt max as a contractility index had similar heart rate between the
groups, which makes the Treppe effect less likely to occur [27, 28]. Ishikawa and colleagues
have demonstrated that the ejection fraction is more sensitive at detecting systolic dysfunction
Fig 3. NF-κB transcriptional activity assay of p50 and p65 detected in nuclear extracts collected from tissues in the remote area. All values
represent the mean ± SE of five independent experiments. A.U.: arbitrary units.
doi:10.1371/journal.pone.0121842.g003
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over the dP/dt max in an elegant model of myocardial infarction in swine. They suggest the
ejection fraction is more suited for inter animal comparisons and dP/dt max is more useful
tool to assess contractility within the same animal [24]. Therefore, the present findings demon-
strate the diaceiren interfere positively on the LV remodeling after MI, but it was unable to pro-
vide any beneficial effect on myocardial contractility state compared to the control group.
These beneficial effects of LV remodeling after MI may have been due to inhibition of
TNFR1, which can lead to lower levels of IκBα activation and reduced transcription of NF-κB
p65. No significant changes in TNF receptor 2 (TNFR2) were observed during the same experi-
mental period. LV remodeling was also associated with lower levels of caspase 3/7 activity, less
fibrosis, less collagen, and reduced procollagen deposition. To our knowledge, the effects of
diacerein on LV remodeling after MI have not previously been investigated. The present find-
ings suggest that modulation of the inflammatory response is a key factor in the healing pro-
cess, in accordance with several reports in the literature [3, 4, 11, 29], supporting the potential
clinical utility of a drug with anti-inflammatory effects after MI.
Remodeling of the LV after MI is a complex process that includes several pathways that me-
diate biochemical, molecular, and morphological alterations in remote and infarcted myocardi-
al regions [19]. The role of innate immunity in this process is not completely understood.
However, it appears that TNF mediates bimodal effects, ranging from tissue injury to tissue re-
pair, during the acute and chronic stages after MI[3, 30]. In the present study, selective inhibi-
tion of TNFR1 was identified as a potential mechanism by which inhibition of IκBα could
regulate the NF-κB p65/p50 heterodimer [31]. This hypothesis is supported by the results of
other studies involving TNFR1 [30, 32, 33]. For example, Hamid and colleagues subjected
Fig 4. Gene expression detected for TNF (A) and IL-1 (B) in remote and infarcted areas.Gene expression detected for IL-6, NF-κB p50, and NF-κB p65
(C) in the remote areas of both groups. All values represent the mean ± SE of three independent experiments.
doi:10.1371/journal.pone.0121842.g004
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TNFR1-/- and TNFR2-/- mice to MI. They observed disparate and opposing effects on LV re-
modeling, hypertrophy, and NF-κB activation, with TNFR1 exacerbating the effects of MI and
TNFR2 improving the response to MI. In the present study, lower levels of TNFR1 expression
were observed with diacerein administration, accompanied by lower levels of fibrosis, caspase
3/7 activity, and NF-κBp65. These results are consistent with those of the TNFR1-/- model
[30].
Onai and colleagues previously demonstrated that non-selective blockage of NF-κB im-
proves LV remodeling after MI in their studies of IMD-0354 and IKK-β phosphorylation[8].
In the present study, selective blockage of TNFR1 resulted in an attenuation of NF-κB p65
transcription, lower levels of caspase 3/7 activity, and improved remodeling of the LV 4 weeks
after treatment with diacerein. TNFR1 has previously been shown to activate TNFR1-asso-
ciated death domain (TRADD), which is involved in mediating apoptosis via recruitment of
caspase 8 and cleavage and activation of caspase 3, and also contributes to the activation of NF-
κB [34]. Onai et al. did not evaluate the effects of IMD-0354 on the NF-κB subunits. However,
Hamid and colleagues reported that persistent inhibition of NF-κB p65, coupled with negligi-
ble NF-κB p50 activation/inhibition, resulted in improved survival and cardiac remodeling.
Decreased pro-inflammatory, pro-fibrotic, and anti-apoptotic effects were observed in trans-
genic mice that over expressed a mutation for phosphorylation-resistant IκB-α and were sub-
jected to coronary ligation [31]. The latter results are consistent with those of the present
study, although lower levels of TNF expression were also accompanied by an absence of
changes in IL-1 and IL-6 gene expression in the present study.
Several reports have shown that NF-κB plays an important role in cardiac remodeling after
MI in animal models and humans [19, 35, 36]. Furthermore, it has been demonstrated that the
NF-κB subunits p50 and p65 translocate to the nucleus up to 24 hours after infarction, yet only
the p65 subunit is consistently stimulated in animals that experience poor LV remodeling
and heart failure [35]. The relationship between innate immunity and LV remodeling after MI
remains unclear, although it appears that chronic activation of NF-κB is detrimental to remod-
eling of the LV [3].Three genetic programs have been identified as being controlled by the
NF-κB pathway, with the timing and type of NF-κB activation being key events [37]. These
programs include hypertrophy, acute cardiomyocyte protection from ischemia/reperfusion,
and chronic cardiomyocyte injury due to a prolonged inflammatory response [30, 31, 37]. In
all three programs, chronic activation of NF-κB appears to represent a maladaptive process
that perpetuates the inflammatory process and compromises repair of LV function due to the
presence of increased fibrosis, reduced myocardial contractility, increased hypertrophy in re-
mote areas, and deterioration of diastolic function [37].
Recently, Gao and colleagues showed a decrease in IκBα phosphorylation in RAW 264.7
cells pretreated with diacerein and stimulated with lipopolysaccharide (LPS)[38]. The decrease
in IκBα phosphorylation was also accompanied by a marked decrease in nuclear levels of NF-
κB p65 compared to the cells that were not pretreated with diacerein [38]. These observations
in an in vitromodel are very similar to those described here in an animal model.
In the present study, diacerein partially blocked the inflammatory process after MI by inhib-
iting the NF-κB p65 subunit. This effect was associated with improved remodeling of the LV
over a period of 4 weeks post-MI. However, different doses of diacerein were not evaluated to
investigate a potential dose-dependent effect. The dose administered was used in a previous
study [17].
There were limitations associated with the present study. First, it is possible that the ob-
served decrease in contractility in the diacerein group was due to greater modulation of the
parasympathetic system. The current data do not address this and further studies are needed.
Second, a clear beneficial effect of diacerin on left ventricle remodeling was observed in the
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present study in the Western blot assays performed. Lower levels of p-IκBα and nuclear NF-κB
p65 were detected in the diacerein group, and similar findings have been reported by Gao and
colleagues [38]. Third, all of the Western blots were performed using total tissue extracts in-
stead of cytosolic fraction extracts, and this may explain the similar observations made regard-
ing IκBα expression levels.
Conclusions and Clinical Implications
In the presence of diacerein, a certain degree of inflammatory blockage, although not complete,
was observed in the rat MI model investigated. This blockade may have contributed to the ben-
eficial effects that were associated with LV remodeling. Given that there are several factors in-
volved in cardiac remodeling, it is encouraging to find that inhibition of NF-κB is capable of
influencing many aspects of this process. Thus, administration of an NF-κB inhibitor may rep-
resent a reasonable therapeutic approach for the treatment of MI.
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